Status:

ACTIVE_NOT_RECRUITING

Correlation of the Arrhythmia Mechanism and Substrate to Ablate Persistent Atrial Fibrillation Study

Lead Sponsor:

Ottawa Heart Institute Research Corporation

Conditions:

Persistent Atrial Fibrillation

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

This is a pilot study to assess the usefulness of ECG mapping, and enhanced MRI and PET scan imaging in identifying atrial fibrosis and arrhythmia circuits involved in persistent atrial fibrillation a...

Detailed Description

Pulmonary vein isolation catheter ablation for the treatment of persistent AF (PeAF)or longstanding persistent AF is associated with success rates of 40-50% at one year. Experimental models have shown...

Eligibility Criteria

Inclusion

  • Age ≥18 years and ≤ 80 years;
  • Symptomatic persistent AF AND clinically indicated for AF catheter ablation
  • At least one episode of AF lasting more than 7 days, documented on 12-lead ECG, Holter monitor, 2-week loop monitor or trans-telephonic monitor (TTM) within 12 months of enrollment in the study
  • Able to provide informed consent.

Exclusion

  • History of previous catheter or surgical ablation for AF
  • Presence of intracardiac thrombus
  • contraindication to systemic oral anticoagulation therapy
  • Subjects with reversible causes of AF
  • Antero-posterior left atrial dimension \> 60 mm on echocardiography
  • Severe valvular disease (mitral/aortic stenosis or regurgitation);
  • Subjects that are pregnant or breastfeeding;
  • Chronic kidney disease and creatinine clearance \<50ml/min.
  • Contraindication to MRI Imaging (e.g. permanent pacemaker, metallic implants, etc)

Key Trial Info

Start Date :

September 14 2015

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 31 2026

Estimated Enrollment :

52 Patients enrolled

Trial Details

Trial ID

NCT02184013

Start Date

September 14 2015

End Date

January 31 2026

Last Update

August 15 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Ottawa Heart Institute

Ottawa, Ontario, Canada, K1Y 4W7

Correlation of the Arrhythmia Mechanism and Substrate to Ablate Persistent Atrial Fibrillation Study | DecenTrialz